Disease | leukemia |
Phenotype | C0040053|thrombosis |
Sentences | 10 |
PubMedID- 24523910 | Additionally, the combination of l-asparaginase and dexamethasone, but not the corticoid prednisone, induced the expression of several hsps, resulting in reduced risk of thrombosis in patients with acute lymphoblastic leukemia [27]. |
PubMedID- 25379622 | Treatment of catheter-related deep vein thrombosis in patients with acute leukemia with anticoagulation. |
PubMedID- 25809122 | Background: thrombosis in patients with acute lymphocytic leukemia (all) can develop after treatment with l-asparaginase (asp) and is often localized to the central nervous system (cns). |
PubMedID- 21787123 | thrombosis in children with acute lymphoblastic leukemia treated at a tertiary care center in lebanon: revisiting the role of predictive models. |
PubMedID- 24717424 | Cerebral venous and sinus thrombosis in a patient with acute promyelocytic leukemia during all-trans retinoic acid induction treatment. |
PubMedID- 23555443 | Retrievable inferior vena cava filter and catheter directed thrombolysis (cdt) for treating a 19-year-old man with acute myeloid leukemia complicated by deep vein thrombosis (dvt): a case report. |
PubMedID- 23198154 | Epidemiologic studies of pediatric thrombosis in leukemia have been greatly emphasized by small numbers, making estimates of thrombosis risk in this condition very difficult [3, 14, 25, 26]. |
PubMedID- 23364161 | We aimed to scrutinize the risk factors for thrombosis in children with acute lymphoblastic leukemia treated with the berlin-frankfurt-munster 95 protocol. |
PubMedID- 20565317 | Superior ophthalmic vein thrombosis in a patient with chronic myeloid leukemia receiving antifibrinolytic and thrombopoietin receptor agonist therapy. |
PubMedID- 24942025 | Massive splenic infarction and portal vein thrombosis (pvt) due to chronic myeloid leukemia (cml) is extremely rare. |
Page: 1